Must Read: How Ozempic Changed the Face of Beauty, Implications of Shein's IPO

These are the stories making headlines in fashion on Friday.

How Ozempic changed the face of beauty
Diabetes drug Ozempic's off-label use for quick weight loss has turned the drug into a cultural phenomenon. The prevalence of Ozempic among celebrities and socialites has also led to a new beauty concern, the so-called "Ozempic face," which is a "suddenly gaunt, hollow-looking … prematurely aged face," Business of Fashion reports. Now, the "snatched" look is somewhat decreasing as clients are changing their minds about once-undesirable roundness and plumpness, Dr. Ahmed El Muntasar, a general and aesthetic practitioner in the UK, told Business of Fashion. Social media searches for "contouring" are also down 10.6% year-on-year, and searches for bronzing products which offer a healthy, all-over glow are up 33% since last year, according to Spate. Since some clients are looking to restore plumpness with facial filler, aesthetics clinics and medical spas are poised to capture residuals from the Ozempic boom. {Business of Fashion/paywalled}

The implications of Shein's IPO
Shein has confidentially filed to go public in the U.S. this week in what is poised to be one of the biggest IPOs in recent years. The ultra-fast fashion retailer has faced criticism surrounding its labor practices and working conditions from sustainability advocates and members of Congress. Within the past year, Democratic Congresswoman Jennifer Waxton led a bipartisan call for the U.S. Securities and Exchange Commission (SEC) to halt Shein's IPO until it verifies that the company does not use forced labour within its supply chain. Susan Scafidi, founder and director of the Fashion Law Institute at Fordham Law School, told Vogue Business that if Shein's IPO is successful, it could skirt further scrutiny of its practice of using de minimis shipping, which has allowed the company to avoid paying tariffs on shipments to the U.S. Many concerns surrounding Shein's potential IPO include how this will impact sustainability efforts in the fashion industry as a whole and if calls for change will become more muted if investors and the wealthy constituents of legislators are more focused on growth and profits. {Vogue Business}

Larroudé launches curated boutique of fashion and wellness products
Luxury footwear brand Larroudé launched Colléct, an online boutique that will spotlight the best designers across fashion and wellness, on Friday. The initial launch features 17 brands, including Retrovai, Lingua Franca, La Vie Style House, Dr. Lara Devagan, Dear Annabelle, Gigi Burns and Jonathan Cohen, among others. Brands will be presented on the website with storytelling in mind, and the site currently is centered around gift-giving. "I want people to come to the site and be surprised by stuff you don't see because it gets lost in a sea of merchandise [on other sites]. I want them to have this great, fun experience," Co-founder Marina Larroudé told WWD. {WWD/paywalled}

Tod's appoints Matteo Tamburini creative director
Tod's has named Matteo Tamburini its new creative director,  after Walter Chiapponi left the brand for Blumarine. Tamburini has worked in the fashion industry since the 2000s, most recently at Bottega Veneta. "I am honored and excited to join the Tod's family and become part of a brand that is so closely tied to my origins and memories," Tamburini said, in a statement. "I identify with the brand's values and the continuous pursuit of high quality and style it has undertaken, and I look forward to contributing with my expertise." His first collection for Tod's will be for Fall 2024, which will be presented in Milan in February. {Vogue/paywalled}

Never miss the latest fashion industry news. Sign up for the Fashionista daily newsletter.